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The bacterium Pseudomonas aeruginosa causes chronic respiratory
infections in cystic fibrosis (CF) patients. Such infections are ex-
tremely difficult to control because the bacteria exhibit a biofilm-
mode of growth, rendering P. aeruginosa resistant to antibiotics
and phagocytic cells. During the course of infection, P. aeruginosa
usually undergoes a phenotypic switch to a mucoid colony, which
is characterized by the overproduction of the exopolysaccharide
alginate. Alginate overproduction has been implicated in protect-
ing P. aeruginosa from the harsh environment present in the CF
lung, as well as facilitating its persistence as a biofilm by providing
an extracellular matrix that promotes adherence. Because of its
association with biofilms in CF patients, it has been assumed that
alginate is also the primary exopolysaccharide expressed in bio-
films of environmental nonmucoid P. aeruginosa. In this study, we
examined the chemical nature of the biofilm matrix produced by
wild-type and isogenic alginate biosynthetic mutants of P. aerugi-
nosa. The results clearly indicate that alginate biosynthetic genes
are not expressed and that alginate is not required during the
formation of nonmucoid biofilms in two P. aeruginosa strains,
PAO1 and PA14, that have traditionally been used to study bio-
films. Because nonmucoid P. aeruginosa strains are the predomi-
nant environmental phenotype and are also involved in the initial
colonization in CF patients, these studies have implications in
understanding the early events of the infectious process in the CF
airway.
The development of bacterial biofilms involves the regulatedand coordinated transition from free-swimming planktonic
bacteria to highly differentiated communities of surface-
attached organisms. In general, this developmental pathway
proceeds from the initial attachment of bacteria to a surface,
followed by the accumulation of cell clusters or microcolonies,
and ultimately, a ‘‘mature’’ biofilm characterized by large mi-
crocolonies of bacteria separated by fluid-filled channels (1–3).
Hallmarks of a mature biofilm include the production of an
extracellular matrix or EPS (for extracellular polymeric sub-
stance) and an increased resistance to antibiotics and antimi-
crobial stress (2). It has been proposed that one component of
EPS, secreted polysaccharides, may contribute to the resistance
of biofilm-grown bacteria to certain antimicrobial agents (4–6).
Besides polysaccharides, EPS is also thought to be composed of
nucleic acids and proteins (7). EPS composition presumably
varies from organism to organism; however, its composition is
ill defined.
The paradigm organism for studying bacterial biofilms,
Pseudomonas aeruginosa, has been long thought to produce
alginate, a polymer of the uronic acids mannuronic and gulu-
ronic acid, as the primary secreted polysaccharide in biofilms (8).
P. aeruginosa isolated from the lungs of cystic fibrosis (CF)
patients, often undergoes a switch to a mucoid phenotype, which
is characterized by the formation of shiny colonies on an agar
plate (9). Mucoidy results from an overproduction of alginate,
which is thought to play a protective role in the relatively harsh
environment of the CF lung, perhaps by enhancing the formation
of biofilms (9). There are several other lines of evidence, which
are consistent with P. aeruginosa existing in the CF lung as
biofilms. This evidence includes microscopy of P. aeruginosa
from the sputum of CF patients, the high level antibiotic
resistance of P. aeruginosa in the CF lung, and the production of
quorum-sensing molecules in sputum in ratios typical of biofilm-
grown bacteria (10–12). The studies of CF-derived mucoid P.
aeruginosa isolates, and their link to the biofilm lifestyle, has led
to the assumption that alginate is the key secreted polysaccharide
in biofilms of both mucoid and nonmucoid strains.
Early studies examining the role of alginate in the initiation or
maturation of biofilms often involved the comparison of mucoid
strains isolated from the CF lung with nonisogenic, nonmucoid
strains (13). These studies generally compared the ability of
these strains to form biofilms and the antibiotic resistance of
established biofilms. Other approaches included examining the
effect of antibodies to alginate on adhesion by mucoid and
nonmucoid strains, which demonstrated that the antibodies did
not inhibit adhesion of nonmucoid P. aeruginosa strains to
eukaryotic cells grown in vitro (13, 14). Unfortunately, data
interpretation is difficult, because compared strains were
nonisogenic. Recently, studies comparing isogenic mucoid and
nonmucoid strains of P. aeruginosa, demonstrated that alginate
overproduction and modification had a dramatic effect on
biofilm structure and resistance to the antibiotic tobramycin (15,
16). However, because most clinical and environmental isolates
of P. aeruginosa are nonmucoid, and biofilm formation is
important in these niches, a careful examination of the role
alginate plays in nonmucoid P. aeruginosa biofilms is warranted.
Despite the great interest in alginate, its biosynthesis, and the
environmental signals that regulate its expression, there is little
direct evidence to date that alginate is a significant component
of wild-type P. aeruginosa biofilms. Perhaps the strongest sup-
porting evidence is the detection of low levels of uronic acid-
positive carbohydrates in P. aeruginosa biofilm EPS, using a
general carbazole assay (17). In this article, we describe a series
of experiments that demonstrate that alginate is not required for
the initiation, maturation, or drug resistance of biofilms formed
by two P. aeruginosa strains, PAO1 and PA14. In addition, gene
fusion analyses, as well as physical and chemical studies of
biofilm polysaccharides, reveal no detectable alginate or alginate
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gene expression in biofilms formed by PAO1 and PA14, despite
the fact that these strains are fully capable of synthesizing
alginate. These data suggest that the relationship between the
conversion of mucoidy and P. aeruginosa biofilms is not simply
a change in the alginate levels present in the biofilm EPS matrix,
but a fundamental change in its carbohydrate constituents.
Materials and Methods
Strains, Plasmids, Media, and Growth Conditions. The P. aeruginosa
strains used in this study are PAO1 (18) and PA14 (19), as well
as algD mutant derivatives WFPA1 (algD::tet) and PA14algD,
respectively. WFPA2 is a complemented (algD) derivative of
WFPA1, generated by gene replacement of the algD::tet allele
with wild-type algD sequences present in pDJW482. P. aerugi-
nosa strains WFPA220 and WFPA222, which harbored ptac-gfp
at the neutral att site in PAO1 or WFPA1, respectively, were
constructed with pTW16 by techniques outlined elsewhere (20).
P. aeruginosa WFPA225 (algD-xylE), WFPA226 (xylE), and
WFPA227 ( fliC-xylE) were generated by similar strategies with
plasmids pTW5, pTW8, and pTW13, respectively. The Esche-
richia coli strains used for routine cloning or mating experiments
were JM109 (Promega) or SM10 (21). Plasmid pDJW487, which
was used to create the algD::tet mutation in strain PAO1, was
generated as follows: an additional XhoI site was created in
pDJW422 [HindIII–XhoI fragment from pCC27 (22)] cloned in
pALTER-1 (Promega) 846-bp upstream of the algD translation
start site by using the Altered Sites technique (Promega) and
oligonucleotide algD37 (5-CGGTAGCGCCTCGAGGCGT-
CGGC-3). The resulting plasmid, pDJW480, was cleaved with
HindIII–XhoI and ligated with an 8-kb XhoI–HindIII fragment
from pCC27 into the HindIII site of the gene-replacement vector
pDJW527 (23). The subsequent plasmid, pDJW485, which har-
bored a deletion of the 5 regulatory and most of the algD coding
sequence, was cleaved with XhoI, treated with treated with the
Klenow fragment of DNA polymerase, and a 2.0-kb SmaI tet
fragment from pHP45Tc (24) ligated in, generating pDJW487.
Plasmid pDJW482, which harbored a 10-kb HindIII fragment
with wild-type algD sequences in pDJW527, was used for
complementation studies. Plasmid pTW16 (ptac-gfp) was de-
scribed (20). Plasmid pTW5, which contains the algD-xylE
operon fusion in miniCTX (21), was constructed by cloning a
1.2-kb HindIII–XhoI fragment containing the algD promoter
adjacent to the promoterless xylE gene from pX1918G (25).
Plasmid pTW8 contains a promoterless xylE gene in miniCTX
and was generated by deleting the 1.2-kb HindIII–XhoI algD
fragment from pTW5, treating with treated with the Klenow
fragment of DNA polymerase, and religation. Plasmid pTW13
harbors a fliC-xylE operon fusion in miniCTX (20). Media,
growth conditions, and antibiotic concentrations for E. coli and
P. aeruginosa are as outlined (20, 23).
Gene Replacement Strategies. Mutants of P. aeruginosa were gen-
erated by gene replacement techniques essentially as described (23,
25), using sacB-mediated counterselection strategies. Introduction
of single-copy operon fusions or ptac-gfp fusions at the neutral attB
site were by procedures outlined earlier (20, 21). All allele replace-
ments and attB-integration events were confirmed by PCR analyses
or Southern hybridizations.
Microtiter Dish and Flow Cell Culturing Techniques for Examining
Biofilm Formation. These assays were performed as described (16,
31). COMSTAT software was applied to confocal microscopy
images derived from flow cell experiments as described (16, 26).
The growth medium used for flow cell experiments was Jensens
medium supplemented with succinate (25 mM; ref. 27).
Biofilm Antibiotic Resistance Assays. For the microtiter dish assay,
overnight bacterial cultures were subcultured into fresh medium,
the bacteria was added to the wells of microtiter dishes (100 l
per well), and the plates were incubated for 24 h. The spent
medium was removed and replaced with fresh medium contain-
ing the antibiotics and the plates were incubated for an additional
24 h. The antibiotic-containing medium was then removed and
replaced with fresh antibiotic-free medium, the plates were
incubated for an additional 24 h (during which time, any viable
cells in the biofilm grew and replenished the planktonic popu-
lation), and finally the medium was assessed for viable cells. The
MBC-biofilm is defined as the minimal concentration of anti-
biotic required to kill all of the bacteria in a preformed biofilm.
Additionally, the rotating disk assay for antibiotic resistance was
performed as reported (16). The antibiotic tobramycin was
applied at a range of 0.5–50 gml.
XylE Fusion Analysis of algD Expression in Biofilms. P. aeruginosa
strains WFPA225 (algD-xylE), WFPA226 (xylE), and WFPA227
( fliC-xylE) were grown in 15  100-mm Petri dishes containing
15 ml of inoculated LB medium at 37°C. Biofilms that formed at
the air-liquid interface were harvested at the time points indi-
cated in Fig. 2, and were assayed for XylE activity by techniques
described elsewhere (20). The XylE enzyme activity was calcu-
lated by using the extinction coefficient of the reaction product,
2-hydroxymuconic semialdehyde (375  4.4  104 M1), and
corrected for the number of cells by dividing by the A540 of the
sample. Activities are thus expressed as nanomolar product
liberated per minute per 109 cells (1 ml with OD540  1). All xylE
constructs were placed at the neutral attB site (20, 21).
Isolation and Analysis of EPS from P. aeruginosa Biofilms. Biofilm
EPS was isolated as described (28). P. aeruginosa strains depicted
in Table 2 were cultured on LB plates covered with cellophane
for 24 h at 37°C. PAO1 EPS was also prepared from biofilms
grown at 37°C on the inside of 12-inch long (1 inch  2.54 cm)
pieces of silicone tubing [inside diameter (i.d.) 2 mm] with LB
medium supplied as the growth medium as described (29).
For carbohydrate analysis, the sample was hydrolyzed with 1.0
M methanolic-HCl for 16 h at 80°C. The released methylglyco-
sides were dried down and N-acetylated by using methanol and
acetic anhydride (1:1; vol:vol) for 15 min at 45°C. The acetylate
sample was trimethyl-sialylated with Tril-Sil and resolved on a
30-m DB-1 column (0.25  0.25 i.d.; J &W Scientific, Folsom,
CA) in a Hewlett–Packard 5985 GC-MS system by using myo-
inositol as an internal standard. The following temperature
conditions were used: an initial temperature of 160°C, then
raised to 200°C at 2°C per min, and increased to 260°C at 10°C
per min. A standard of derivatized methylglycosides were also
run alongside the samples for identification.
For linkage analysis, the sample was methylated by using the
NaOHMel method (2). The methylated material was then
isolated by extraction into methylene chloride, dried down, and
subjected to sequential hydrolysis (2 M of trif luoroacetic acid at
120°C) reduction (NaBD4) and acetylation (acetic anhydride,
pyridine). The resulting partially methylated alditol acetates
were analyzed by GC-MS using a fused-silica, 30-m Sp2330
column in a Hewlett–Packard 5985 GC-MS system, using myo-
inositol as an internal standard. The following temperature
conditions were used: starting with 2 min at an initial temper-
ature of 80°C, which was increased to 170°C at 30°C per min, then
to 240°C at 40°C per min, and held at 5 min at 240°C.
Uronic Acids Assay. Levels of uronic acid-positive material, in-
cluding alginate, were determined directly from the supernatant
fraction of planktonic P. aeruginosa cultures, using the carbazole
assay as described, with modifications (23, 30), and Macrocystis
pyrifera-derived alginate (Sigma) as a standard. This assay was
also performed on biofilm biomass of P. aeruginosa strains
recovered from microtiter dishes (31). Planktonic and biofilm
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cultures were grown for 22 h at 30°C with LB as a growth
medium.
Results
Alginate Expression Is Not Required for Initial Stages in Biofilm
Development. Secreted polysaccharides have been shown to play
a role in both the attachment of bacterial cells to surfaces and
dictating the structure of mature biofilms. Therefore, we hy-
pothesized that alginate would play an important role in one
stage or possibly multiple stages of P. aeruginosa biofilm devel-
opment. The majority of the genes involved in alginate biosyn-
thesis, modification, and secretion are clustered in a large operon
(PA3540-PA3551) (32, 33). The first gene of this operon, algD,
encodes GDP mannose dehydrogenase, an enzyme essential for
alginate synthesis (34). The algD gene product catalyzes the first
committed step in alginate synthesis and is not known to be
required for any other cellular process. We assayed algD mutants
in two P. aeruginosa strains classically used to study biofilms
PAO1 and PA14 (35) and compared the kinetics of biofilm
formation with isogenic wild-type strains, using the microtiter
dish assay. Fig. 1A shows the kinetics of biofilm formation of P.
aeruginosa PAO1, its algD derivative, WFPA1, as well as
WFPA2, a strain complemented with wild-type algD sequences,
using gene replacement strategies. To our surprise, all three
strains exhibited no observable difference in the rate or extent
of biofilm formation over the 8-h testing period. Similarly, the
amount of biofilm biomass produced by strain PA14 at 8 h (data
not shown) and by PAO1 at 24 h (Fig. 1B) was identical to the
biofilm formed by the algD strain used in this assay. These data
suggest that alginate is not required for the early steps in biofilm
initiation for either PAO1 or PA14.
To further explore the role of alginate, we examined algD
expression in P. aeruginosa biofilms. We constructed two PAO1-
derived strains, WFPA225 and WFPA227, which harbored
ectopic chromosomal operon fusions of the promoterless xylE
gene with algD or fliC, respectively. The fliC gene, which encodes
flagellin, the major structural subunit of the P. aeruginosa
f lagellum, was chosen as a positive control because earlier
studies indicated that flagellar-mediated motility is required for
biofilm initiation (31). In addition, strain WFPA226, which
harbors a promoterless xylE gene was generated. Previous
studies (36) have suggested that expression of alginate biosyn-
thetic genes is induced after attachment of P. aeruginosa to a
surface. Therefore, this study was performed by using microtiter
dish-grown biofilms, which facilitates analysis of early events in
biofilm development. As depicted in Fig. 2, whereas fliC-xylE
expression was readily observed, no algD expression was de-
tected in biofilm-grown cells. To further verify the functionality
of this reporter construct, we introduced the algT gene in trans
into PAO1 harboring the algD-xylE reporter. AlgT is an alter-
native -factor that induces expression of the alginate biosyn-
thetic operon. Expression of the algD-xylE fusion was induced at
least a hundred-fold when algT was supplied in trans (data not
shown).
The Architecture and Antibiotic Resistance Profiles of Wild-Type and
Alginate-Deficient Biofilms Are Identical. Unlike microtiter-plate-
grown biofilms, f low cell biofilm cultures are amenable to
microscopy and allow the culturing of biofilms for longer periods
of time. Because alginate expression may have an effect on
Fig. 1. Biofilm formation by P. aeruginosa PAO1 and PA14 strains. (A) Biofilm
formation of PAO1, WFPA1 (algD::tet), and WFPA2 (algD derivative of
WFPA1). Biofilm formation was assayed every 2 h during initiation by using the
microtiter plate assay (47). Surface-attached cells were stained with crystal violet,
the stain was solubilized in ethanol, and the absorbance was analyzed at 600 nm.
(B) Biofilm formation of P. aeruginosa PAO1 and WFPA1 in a flow cell system as
described in Materials and Methods. The bacteria in the micrograph are labeled
with GFP. These micrographs were taken 24 h after inoculation of the system. The
micrographs presented are a top-down view of the biofilm (TD) or a side view (S)
generated with scanning confocal laser microscopy (SCLM) . The magnification is
630. (Scale bar, 10 m.) (C) COMSTAT analysis of confocal micrographs generated
at different time points in B.









biofilm structure and may play a role at later stages of biofilm
formation, we decided to use flow cells to monitor biofilm
development over time. We generated GFP-tagged derivatives
of PAO1 (WFPA220) and a algD::tet derivative (WFPA222)
and combined flow cell culturing technology with confocal
scanning laser microscopy (CSLM) to examine the architecture
of these strains. There were no observable differences in biofilm
structure between the two strains throughout the course of
biofilm growth (up to 72 h). A representative fluorescent
micrograph displaying the architecture of a 24-h-old biofilm is
shown in Fig. 1B. PA14 and PA14algD also produced biofilms
that were indistinguishable by microscopy (data not shown). We
used the COMSTAT software package to quantify three key
parameters of biofilm architecture from the CSLM images
generated from flow cell biofilms: average biofilm thickness,
biofilm roughness (a measure of biofilm heterogeneity), and
total biofilm biomass (Fig. 1C). Interestingly, PAO1 produced
biofilms with little structural heterogeneity in this growth me-
dium, although this phenomenon has been previously reported
for this bacterium. These data support the finding that alginate
is not required for the formation and maintenance of biofilm
architecture in P. aeruginosa PAO1 and PA14. Taken together,
the data in Figs. 1 and 2 strongly suggest that alginate plays no
significant role in biofilm development.
Alginate and Antimicrobial Resistance. A hallmark characteristic of
biofilm populations is their increased antimicrobial resistance to
planktonic bacteria of the same species (2, 3). Previous studies
have demonstrated that exopolysaccharide production can in-
f luence the antimicrobial resistance properties of biofilms.
Therefore, we compared the antibiotic resistance profiles of
wild-type and algD mutant biofilms using two experimental
systems. In the first system, biofilms are formed in microtiter
dishes for 24 h, treated with antibiotics for 24 h, then viable cells
remaining are determined. In this assay, antibiotic resistance
increases from 10- to 100-fold over planktonically grown cells,
depending on the antibiotic tested. The results of these assays are
shown in Table 1. We observed no difference in the antibiotic
resistance of the wild-type or algD mutant in the P. aeruginosa
PA14 background for the three antibiotics tested. Similarly, the
resistance profiles of the PAO1 strains are nearly identical for
tobramycin and gentamycin. Interestingly, the algD mutant of P.
aeruginosa PA14 appears to have increased resistance to cipro-
floxacin, although the basis for this increased resistance is not
clear.
The second experimental system is a spinning disk reactor,
previously used to evaluate antibiotic resistance in P. aeruginosa
biofilms (16). This reactor allows cultivation of biofilms on 18
polycarbonate chips, which are inserted into a lexan disk. This
disk is rotated in a bacterial chemostat liquid culture. The chips
can be removed and the biofilms subjected to antibiotic treat-
ment. The antibiotic resistance of the biofilm population can
then be compared with the chemostat liquid culture. Besides
providing complementary data for the microtiter plate analysis,
this reactor system also allows a more careful statistical com-
parison of antibiotic-resistance profiles of biofilm populations.
PAO1 and algD biofilms grown for 24 h were subjected to a
range of tobramycin concentrations (0.5–50 gml) for 5 h. The
antibiotic-resistance profiles were similar for the two strains,
with the MBC for tobramycin at 25 gml (data not shown).
These results indicate little or no role for alginate in the
enhanced antibiotic-resistance phenotypes of biofilm-grown
PAO1 and PA14 P. aeruginosa.
Analysis of Planktonic and Biofilm EPS Using a Uronic Acids Assay.
Previous studies (37, 38) implicating alginate in P. aeruginosa
biofilms relied on a chemical carbazole-based assay for detection
of uronic acids (17). We applied this assay to planktonic and
biofilm-grown PAO1, the algD strain WFPA1, PDO300, a
mucA derivative of PAO1, which produces alginate (16), and
FRD1, an alginate-producing CF isolate (39). We readily de-
tected uronic acids from both PDO300 and FRD1, yet were
unable to observe differences between PAO1 and WFPA1, even
though they both produced low amounts of material that reacted
in the carbazole assay (Table 2). This finding suggests that some
component of EPS derived from a source other than alginate is
responsible for the weak activity detected in this assay.
Chemical Analysis of Biofilm-Grown P. aeruginosa EPS. The data
described above indicated that alginate was neither expressed
nor required for biofilm structure or antibiotic resistance. We
wished to directly examine the exopolysaccharide composition of
the EPS of biofilm populations. Specifically, we wanted to
determine whether mannuronate or guluronate residues, indic-
Fig. 2. Alginate gene expression in P. aeruginosa biofilms. Expression of
alginate (algD) and a positive control (fliC) at different time points after
biofilm formation at an air-liquid interface (see Materials and Methods). This
graph shows XylE activity of three different reporter strains over time. The
negative control (xylE) harbors a promoterless fusion gene integrated onto
the chromosome. The strains used for this experiment were WFPA225 (algD-
xylE), WFPA226 (xylE), and WFPA227 (fliC-xylE).
Table 1. Antibiotic resistance profiles of P. aeruginosa biofilms
Drugstrain PA14 PA14 algD PAO1 PAO1 algD
Gm 0.25 0.25 0.25 0.25
Tb 0.1 0.1 0.1 0.1
Cip 0.005 0.25 0.025 0.025
MBCs are all in mgml.
Table 2. Uronic acids assay on planktonic supernatants and
biofilm EPS
Strain Genotype
Uronic acid, g uronic acid
OD600 culture
Planktonic Biofilm
PAO1 Wild-type 2.2  0.2 7.6  1.0
WFPA1 PAO1 algDtet 2.4  0.3 9.3  1.2
PDO300 PAO1 mucA22 9.6  0.4 26.4  4.0
FRD1 CF isolate mucA22 38.8  1.7 48.7  6.5
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ative of alginate, could be detected. To accomplish this goal, we
used a procedure recently performed to define the Vibrio
cholerae rugose-associated EPS (28). EPS was partially purified
from biofilms of several P. aeruginosa strains grown on solid
medium and the sugar monomer and linkage composition was
determined (see Materials and Methods). The carbohydrate
composition of EPS prepared from PAO1 and the isogenic
algD strain were nearly identical (Table 3). Significantly, there
was no detectable mannuronic or guluronic acid present in the
EPS preparations of either PAO1 or PA14. The primary carbo-
hydrate constituents of the biofilm EPS were glucose, rhamnose,
and mannose. An analysis of the algD mutant of PAO1 revealed
an EPS profile similar to PAO1 (Table 3). Interestingly, an
unknown amino sugar was detected in the PA14 EPS. The
presence of N-acetyl sugars, as well as ketodeoxyoctulosonate
(KDO), indicated the presence of a low level of lipopolysaccha-
ride in the EPS sample. As a control, EPS was purified from an
isogenic mucoid PAO1-derivative, PDO300. As expected, an
analysis of the EPS harvested from PDO300 revealed that the
primary sugar detected was mannuronic acid. These results are
consistent with previous analyses of mucoid P. aeruginosa, which
demonstrated that mannuronic acid is by far the primary car-
bohydrate component (40). To verify that the EPS of biofilms
grown on solid medium is comparable to biofilms grown in flow
cells and other liquidsolid interface biofilm culturing methods
used in this article, we determined the monomer composition of
PAO1 EPS isolated from biofilms grown on the interior of
silicone tubing fed with a continuous supply of LB. We found
that the monomer composition was almost identical to the EPS
data presented in Table 3 (data not shown). The biofilm carbo-
hydrate EPS was further characterized by glycosyl linkage anal-
ysis (Table 4). The primary linkages observed in the EPS were
3-linked, 4-linked, and 6-linked glucose, 2-linked and 3-linked
rhamnose, and 2-linked and 4-linked mannose.
Discussion
In this article, we provide experimental evidence that alginate is
not a major constituent of the extracellular matrix of P. aerugi-
nosa PAO1 and PA14 biofilms. Wild-type and alginate biosyn-
thetic mutants formed biofilms that had no difference in struc-
tural architecture or antibiotic sensitivity. Furthermore,
transcriptional reporter fusion data indicate that alginate bio-
synthetic gene expression is not induced on initiation of biofilm
formation in a microtiter plate assay. A uronic acids assay
traditionally used to detect alginate in biofilm samples was shown
to have similar, low levels of activity on samples prepared from
both a wild-type and an algD mutant strain. This finding indicates
something other than alginate is crossreacting in the assay.
Finally, a chemical analysis of carbohydrate monomers of PAO1
biofilm EPS failed to detect either of the primary sugars of
alginate.
Many previous studies have focused on the role alginate plays
in mucoid strains of P. aeruginosa. In these studies, alginate
overproduction was shown to influence biofilm architecture and
sensitivity to the antibiotic tobramycin (15, 16). O-acetylation of
alginate has also been shown to affect the architecture of P.
aeruginosa biofilms (15). Previous studies by Davies et al. (36)
measured expression of algC, an alginate biosynthetic gene, and
found that expression was induced upon attachment to a surface.
These data were generated in a mucoid derivative of PAO1,
8830. Interpretation of this data is complicated by the fact that
the algC gene product is also involved in the biosynthesis of
rhamnolipid and lipopolysaccharide (LPS). Wingender et al. (41)
analyzed the sugars present in a mucoid strain of P. aeruginosa,
SG81, and demonstrated that besides uronic acids, other carbo-
hydrates were present in the sample. Perhaps the strongest
evidence that alginate might be an important component of
biofilms is the fact that EPS prepared from P. aeruginosa biofilms
have detectable levels of uronic acids. Combined with the data
that PAO1 and algD supernatants show identical levels of low
activity in the assay suggests that some other component of
biofilm EPS is responsible for this activity.
Our findings indicate that alginate is not the primary structural
matrix or ‘‘scaffolding’’ of P. aeruginosa PAO1 and PA14 bio-
films. Structural and antibiotic-resistance profiles of wild-type
and algD mutant biofilms are indistinguishable, both in PAO1
and PA14. This result raises the question as to what, if any,
secreted polysaccharides are important in P. aeruginosa biofilm
development. A recent study indicates the importance of nucleic
acids for the structural integrity of a P. aeruginosa biofilm in the
early stages of development (42). Interestingly, this nucleic acid
reacted in the carbazole assay and may contribute to the low level
of reactivity we observe in PAO1 and DalgD liquid culture
supernatants or biofilms (42). Another candidate molecule that
might provide structural integrity to a biofilm is LPS. LPS has
been demonstrated to affect attachment of bacteria to a surface
(43). Many of the sugars identified in our carbohydrate analysis
correspond to sugars found in P. aeruginosa LPS (e.g., KDO,
N-acetyl sugars, glucose, etc). Both rhamnose and glucose are
core monosaccharides, whereas rhamnose is also an important
component of A-band LPS (44, 45). The presence of 2-linked and
3-linked rhamnose sugars further supports that our EPS samples
contain LPS sugars (Table 4). However, there are other sugars
present in the EPS samples that are not associated with LPS,
such as xylose and mannose. Why xylose is present in PAO1
biofilm EPS and not in the algD mutant is unclear. Interestingly,
Table 3. Biofilm EPS carbohydrate monomer composition profiles
Carbohydrate PAO1 PDO300 algD PA14
Mannuronic acid 0.0 100.0 0.0 0.0
Glucose 41.0 0.0 56.0 37.9
Rhamnose 14.3 0.0 6.4 20.7
Galactose 0.0 0.0 12.4 1.9
Mannose 13.9 0.0 8.5 4.7
Xylose 9.7 0.0 0.0 0.0
KDO 9.1 0.0 7.0 5.3
N-acetyl galactosamine 1.9 0.0 0.0 0.0
N-acetyl fucosamine 7.5 0.0 6.1 0.0
N-acetyl glucosamine 2.6 0.0 3.6 3.8
N-acetyl quinovosamine 0.0 0.0 0.0 18.1
Unknown amino sugar 0.0 0.0 0.0 7.5
Data are presented as percent molar composition.















*Ratio of the GC peak areas with 3-linked glucose set to 1.0.
†GC peaks not fully resolved.









PA14 biofilm EPS not only lacked detectable uronic acids, but
indicated the presence of an unidentified amino sugar. These
data suggest that some other, yet unidentified exopolysaccha-
ride, might be the predominant scaffolding in P. aeruginosa
wild-type biofilms. Previously, P. aeruginosa was reported to
produce a secreted polysaccharide composed of primarily man-
nose and rhamnose (46). This polysaccharide could potentially
play a role in PAO1 and PA14 biofilms. However the linkage
data (Table 4) suggest against the presence of this type of EPS,
because the type of mannose and glucose linkages specific to that
EPS were not detected in our analysis. We should also emphasize
that although alginate was not found to be important for PAO1
or PA14 biofilms for any of the culturing methods or assays used
in this article, we cannot rule out the possibility that alginate
expression is important for biofilm development or function
under yet unidentified environmental conditions.
The transition of P. aeruginosa from a nonmucoid to a mucoid
phenotype has severe consequences in CF pathogenesis and
biofilm formation. The role of alginate in mucoid biofilms is
unquestionably important. However, one must consider that the
onset of biofilm formation in the CF lung during initial coloni-
zation likely precludes the switch to a mucoid phenotype.
Although these data were generated from laboratory biofilms
grown on abiotic surfaces, they suggest that this transition from
a nonmucoid to a mucoid phenotype may involve a switch from
an as-yet-unidentified exopolysaccharide as being the primary
polysaccharide component of EPS to alginate. Understanding
the dynamic nature of P. aeruginosa biofilm EPS production and
regulation will shed new light on understanding chronic biofilms
in CF.
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